Among the Amish, c. 1960s

Victor McKusick’s pioneering investigations provided insight into hereditary disorders.

Written byDiana Kwon
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SNAPSHOTS: In addition to being a prolific scientist, Victor McKusick was an avid photographer. “He documented everything with his camera,” Francomano says. “His collection of photographs is unparalleled.” This was a bit of an issue among the Amish, she adds, because taking pictures ran counter to their community’s beliefs. However, they often agreed to have snapshots taken for medical purposes. Here McKusick photographs the hands of an Amish child with Ellis–van Creveld syndrome. THE ALAN MASON CHESNEY MEDICAL ARCHIVES OF THE JOHNS HOPKINS MEDICAL INSTITUTIONSIn the early 1960s, Victor McKusick, an American clinician and scientist, was in the early stages of his pioneering work in the field of medical genetics. He had recently left cardiology, and, after amassing over more than a decade’s worth of data on inherited connective tissue disorders, had established Johns Hopkins University’s first medical genetics program and clinic in 1957.

Around this time, a forthcoming book and an article drew McKusick’s interest to Amish communities. The book, Amish Society by sociologist John Hostetler, which McKusick reviewed for Johns Hopkins University Press before publication, made him realize that the Amish—who reside in groups founded by a small number of couples, stay isolated from the rest of society, and carefully document their genealogy—would be a perfect community in which to examine recessive phenotypes. Recessive disorders are more common in groups of genetically similar individuals because parents with shared ancestry tend to bear children with large homozygous regions in their genomes.

The other publication that captured McKusick’s attention was a magazine article by a physician, David Krusen, that noted high rates of achondroplasia, a common form of dwarfism, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile

Published In

May 2018

Rare Diseases

The realities of studying uncommon conditions

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies